We are an innovation-driven,
added value investment partner
Our First Priority = People
At TPTF, we believe the cornerstone of every great company is great people. Before a fascinating innovation can become a game-changing company on a global scale, we believe there needs to be daring entrepreneurs to convert the concept into reality.
In addition to providing capital, we consider ourselves a committed partner, supporting our entrepreneurs via our extensive international resources, deep domain expertise and, most importantly, our passion to work together to build great companies.
Our Focus Area
Innovations that change the world
We Are Partnering with the Most
Reputable Research Powerhouses Worldwide,
and Other Honored but Private Investors
Goldie Chang is an Analyst at TPTF. Before joining TPTF, she served as an analyst of Goldman Sachs Global Investment Research division based in Singapore. She graduated from Department of Finance at National Taiwan University.
Mingyi is a Principal at TPTF and has over four years of venture capital related industry experience. She is currently focused on the biomedical sector and is primarily responsible for strategic planning, investment analysis, and other investment operations in the biomedical industry. Prior to joining TPTF, she specialized in investment evaluation, portfolio management and coordinated cross-border partnerships for Cheng Xin Technology Development Corp. and FAT Capital Management. She has also managed and exited several venture capital investments in the life science sector with exceptional returns. Mingyi received a B.S. from National Taiwan University, an M.S. from Cornell University and an M.A. from Columbia University.
David has approximately 20 years of experience in fund management and venture capital investing in Asia, with a focus on Greater China. He has completed 30+ cross border transactions encompassing venture capital and private equity investment, merger and acquisition, fund-raising & IPO, and business facilitations. Prior to joining TPTF, David worked in several investment and fund management positions, including as a General Partner of the Integral Investment Group, a Managing Director and CFO of CEY Capitals Management, and a Fund Manager at Transpac Capital. He also held positions in Hong Kong for ING Barings and Banque Indosuez Group covering Greater China markets. David received his MBA from Columbia University and his BA from the National Taiwan University.
Andrew is a Principal at TPTF and has over 10 years’ experience in technology investments. Previous to joining TPTF, Andrew worked for a US venture capital fund, assisting in developing financial models, business plans and market strategies. He has also worked with several growth companies in multiple industries as well as with the board of directors of numerous portfolio companies on product development, sales management, public relations and corporate strategy. Andrew received his MBA in Finance from the University of Tennessee and his BSM from Tulane University.
Bruce has over 10 years of industry experience in semiconductor industry, currently serves as Principal in TPTF. He is responsible for investment evaluation, due diligence and other venture operational activities. Prior to joining TPTF, Bruce worked for United Microelectronics Corporation (UMC) specializing in IC foundry-related engineering, quality assurance, customer service, and business management. Bruce earned his M.S. and B.A. from National Cheng Kung University.
Barry has approximately 10 years of experience in venture capital fund management and direct investments. Prior to joining TPTF, he served as an Investment Manager at China Development Industrial Bank (CDIB) and Partners, focusing on fund management and investments. He has also worked in various capacities with top international companies including business development, direct investment/M&A, and finance. Barry received his MBA from the Marshall School of Business at the University of Southern California and his BS in Biotechnology from the University of Pennsylvania.
Lizzie is Principal in TPTF. She invests at the intersection of healthcare, device, technology, and data. She is passionate about the discovery of new drug approaches, digitalization of healthcare, genomics, innovative medical instruments, synthetic biology, personalized nutrition, and other deep sciences. Prior to joining TPTF, Lizzie was an investment professional at Sinopac Venture Capital and Singapore family office fund Enspire Capital, where she sourced and led multiple early stage technology investments across Silicon Valley, China, and Taiwan. She graduated from London School of Economics with a Master of Science in Finance.
Jim is a Principal in TPTF, focusing on the evaluation and investment in high tech companies. Prior to joining TPTF, he held various hardware/software engineering positions in Symbol Technologies and Telxon Corporation (both now part of Motorola), Silicon Graphics and Innomedia Inc. Jim also has had experience as an entrepreneur, having co-founded IC Media Corporation in the CMOS image sensor business and served as director, VP, EVP, and CTO positions (the company was later acquired by MagnaChip). He then moved on to become VP of Internet Service & Solutions in Ellie Mae and VP of Engineering in ProImage Technologies. Jim later joined the SoC Technology Center of ITRI which was merged into Information and Communications Research Laboratories where he was responsible for new business development, including spin-off and international collaboration. Jim received his B.S. degree in electrical engineering from National Taiwan University and his M.S. and Ph.D. degrees in computer science from University of Illinois at Urbana-Champaign, respectively. He holds 20 U.S. and Taiwan patents and has 14 publications in conferences and journals.
Yusuke has over 15 years of experience in venture capital investment and fund management in Japan, Greater China Region and Southeast Asia. Prior to joining 360ip, he was an investment manager at Japan Asia Investment Co., Ltd., where he worked in Tokyo, Singapore and Shanghai and led investments in healthcare, ICT, and other industries in Japan, Singapore, Malaysia, China, Taiwan and Hong Kong. He graduated with a MS of Engineering in Biotechnology and Life Sciences from Tokyo University of Agriculture and Technology.
Sarah serves as Finance Director. Prior to joining TPTF, Sarah served as Finance Controller for several large, multinational organizations, including Optoma Corporation and Dentsu, Young & Rubicam, Inc. She began her career as an accounting professional by working at two of the Big Four accounting firms in Taiwan as a registered CPA serving international clients, such as Intel, Oracle, Omron and WPP PLC. Sarah then served as a Project Manager at the Taiwan Futures Exchange (TAIFEX). To promote TAIFEX products, Sarah planned and conducted serval international events and investment conferences and developed programs to help promote the registration of TAIFEX products internationally. Sarah graduated with a degree in Accounting from the National Chung-Hsin University and received her MBA in both Corporate Finance and Derivatives at Loyola University in Chicago.
Wei-Pu is an Analyst at TPTF. Prior to joining TPTF, he served as a member of the Research Staff and the Project Coordinator at the Department of Ophthalmology at the Columbia University Medical Center, focusing on retinal diseases and genetics. Wei-Pu received his MS degree of Biomedical Engineering from Columbia University and his BS in Material Science and Engineering from National Tsing-Hua University.
Volker brings 23 years of hands-on investment and innovation management experience in Germany, the US and across Asia. Prior to joining TPTF as Venture Partner, Volker has worked with multinational corporations such as Google, Audi, AT&T, Commerzbank, and Rutberg & Co. In 2010, Mr. Heistermann co-founded Yushan Ventures, Inc. The firm’s extended portfolio includes investments in Twilio, Ethereum and Zephyrus Biosciences and has resulted in six exits. Volker earned his B.A. in Financial Law from the University of Bielefeld (Germany) and an International Marketing from the University of California, Berkeley. He is also an Advisor to APEC and a member of the Dedicated Short-Range Communication (DSRC) – SEA Work Group.
Lee focuses on investments in the TMT and Healthcare sectors at TPTF, based in Silicon Valley. He has a wealth of experiences over the past decade across Investment Banking and Principal Investment with Morgan Stanley and Nomura; Startup operations with NeuroSky – a Silicon Valley venture-backed digital health company; as well as Venture Capital investments with WI Harper, where he led investments and portfolio managements primarily in the digital health, IOT, and robotics areas. Lee received his B.S. in Electrical Engineering from National Chiao-Tung University in Taiwan, M.S. in Information Networking from Carnegie Mellon University, and a M.B.A. from The Wharton School at University of Pennsylvania.
Jason has had more than 20 years of technology investment experience. Prior to joining TPTF as Venture Partner, Jason was the Team Lead of the Venture Capital Group at Cheil Worldwide (a subsidiary of the Samsung Group), where he established and managed a dedicated fund for investing in promising technology companies. Previously, Jason was the General Manager of LS Corporation’s Strategic Planning and Business Development Group, where he evaluated potential investment opportunities and fund investments, and an Investment Principal at LB Investments, where he completed and exited several international portfolio companies. Jason started his career in research at Samsung Electronics and LG Electronics. He earned his MS and BS in Electrical Engineering at KAIST.
Boh Soon has more than 30 years of investment and technology experience. Prior to joining TPTF as Venture Parter, Boh Soon was the CEO of the Kuwait Finance House in Singapore, the CEO of Vietcombank Fund Management Company in Vietnam — where he established several investment funds — and served in various senior management positions at UBS Capital Asia, Singapore Technologies Group and Rothschild Ventures Asia. Boh Soon received his M.S. and Ph.D. degrees from the University of Strathclyde. He is a Fellow of the Singapore Institute of Directors, and is currently an Independent Director on the board of 5 publicly-listed companies in Singapore, Malaysia and Hong Kong.
12F, No.149, Xinyi Rd Sec.3, Da-an District, Taipei City, Taiwan